ARDX

Ardelyx, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-19

Figures on this page computed 2026-11-08 12:48 UTC

Last close

2.99USD

Market data, 2026-11-05

Except where said otherwise: 10-K for 2025, filed 2026-02-19

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001437402-26-000013
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-19
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001437402-26-000013
Reported in
USD
- 10-K for 2025, filed 2026-02-19
- 10-K for 2025, filed 2026-02-19
- 10-K for 2025, filed 2026-02-19
- 10-Q for 2025, filed 2026-11-03
- 10-K for 2025, filed 2026-02-19
- 10-Q for 2025, filed 2026-11-03
The filing itself
-15.1%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001437402-26-000013
Reported in
USD
- 10-K for 2025, filed 2026-02-19
- 10-K for 2025, filed 2026-02-19
The filing itself
-10.8%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001437402-26-000013
Reported in
USD
- 10-K for 2025, filed 2026-02-19
- 10-K for 2025, filed 2026-02-19
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001437402-26-000013
Reported in
USD
- 10-K for 2025, filed 2026-02-19
- 10-Q for 2025, filed 2026-11-03
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

3.72x

0.73x

0.55x

2.52x

1.02x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-05

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-02-19

Sales3.72x
Its own average over 9 years, 109.5M.
Profit0.73x
Its own average over 10 years, -84.9M.
Free cash flow0.55x
Its own average over 10 years, -79.8M.
Debt2.52x
Its own average over 8 years, 82.4M.
Price1.02x
Its own average over 11 years, 3. Market data, 2026-11-05

Sales is furthest from its own average, at 3.72 times.

Sales is 3.72 times its own 9-year average; Profit is 0.73 times its own 10-year average; Free cash flow is 0.55 times its own 10-year average; Debt is 2.52 times its own 8-year average; Price is 1.02 times its own 11-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-02-19

Sales against its own 9-year average3.72
Source
filed
Statement
income
Fiscal year
2025
Accession
0001437402-26-000013
Reported in
USD
The filing itself
Profit against its own 10-year average0.73
Source
filed
Statement
income
Fiscal year
2025
Accession
0001437402-26-000013
Reported in
USD
The filing itself
Free cash flow against its own 10-year average0.55
Source
filed
Statement
income
Fiscal year
2025
Accession
0001437402-26-000013
Reported in
USD
The filing itself
Debt against its own 8-year average2.52
Source
filed
Statement
income
Fiscal year
2025
Accession
0001437402-26-000013
Reported in
USD
The filing itself
Price against its own 11-year average1.02Market data, 2026-11-05
Source
market
Taken on
2026-11-05
Reported in
USD